Search

Displaying results 4461 - 4470 of 8412 in total
  1. Drug

    Bufexamac

    go.drugbank.com/drugs/DB13346
    ApprovedWithdrawn

    The use of bufexamac has been discontinued in Canada and the United States, which may be due to undetermined clinical efficacy and a high prevalence of contact sensitization [A32822].

    Synonyms: 2-(p-Butoxyphenyl)-acetohydroxamic acid, p-Butoxyphenylacetohydroxamic acid
  2. Drug

    Etretinate

    go.drugbank.com/drugs/DB00926
    ApprovedWithdrawn

    Etretinate was taken off the market in Canada in 1996 and America in 1998 due to the risk of birth defects. Etretinate is now used to treat T-cell lymphomas.

  3. Drug

    Methylcellulose

    go.drugbank.com/drugs/DB11228
    ApprovedInvestigational

    The Degree of Substitution (DS) of a given form of methyl cellulose is defined as the average number of substituted hydroxyl groups per glucose with a theoretical maximum of 3, however more typical values

  4. Drug

    PRG-A01

    go.drugbank.com/drugs/DB18613
    Investigational

    PRG-A01 is a novel inhibitor of Cu, Zn-superoxide dismutase (SOD1) misfolding and aggregation.

  5. Drug

    Cefoselis

    go.drugbank.com/drugs/DB19513
    Experimental

    Cefoselis has a monoisotopic molecular weight of 522.11 Da.

  6. Drug

    Elisidepsin

    go.drugbank.com/drugs/DB19522
    Experimental

    Elisidepsin has a monoisotopic molecular weight of 1476.93 Da.

  7. Drug

    Cargutocin

    go.drugbank.com/drugs/DB19643
    Experimental

    Cargutocin has a monoisotopic molecular weight of 915.48 Da.

  8. Drug

    Cyprolidol

    go.drugbank.com/drugs/DB19771
    Experimental

    Cyprolidol has a monoisotopic molecular weight of 301.15 Da.

  9. Drug

    Pamicogrel

    go.drugbank.com/drugs/DB19812
    Experimental

    Pamicogrel has a monoisotopic molecular weight of 448.15 Da.

  10. Drug

    Nobiprostolan

    go.drugbank.com/drugs/DB19814
    Experimental

    Nobiprostolan has a monoisotopic molecular weight of 468.35 Da.